See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Sept. 25, 2006

Migraine and Cluster Headaches Contraception Erectile Dysfunction

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Migraine and Cluster Headaches

This study will evaluate an FDA-approved medicine to prevent migraine headaches. Volunteers 18-65 may be eligible who have at least a one-year history of migraines, have migraines 10-14 days per month, and are willing to substitute current migraine medicine with the study drug.

The research site is in Cincinnati, Ohio.

More information

Please see



Women are needed for this clinical research study of an investigational oral birth control medication. Women 18-45 who are sexually active and have regular menstrual cycles may be eligible. Compensation up to $150 is available for time and travel.

The research site is in Moorestown, NJ.

More information

Please see


Erectile Dysfunction

This study will evaluate an investigational medication to treat abnormal cholesterol and erectile dysfunction. Men 18-64 in a stable heterosexual relationship who have had ED for at least six months and who are on a stable dose of a cholesterol-lowering drug may qualify.

The research site is in Lawrenceville, NJ.

More information

Please see


Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.